Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Current pharmaceutical design

Showing results (11-20 of 10,640) with videos related to

Pageof 1,064
Sort By:
Current Pharmaceutical Design|January 21, 2011
P-selectin antagonism in inflammatory diseaseKevin J Woollard, Jaye Chin-Dusting
Current Pharmaceutical Design|January 21, 2011
Cytoprotection by natural and synthetic polyphenols in the heart: novel mechanisms and perspectivesFan Jiang, Catherine W T Chang, Gregory J Dusting
Current Pharmaceutical Design|January 7, 2011
Pathobiology of stent thrombosis after drug-eluting stent implantationMarc Vorpahl, Saami K Yazdani, Masataka Nakano, et al.
Current Pharmaceutical Design|January 7, 2011
Biodegradable and bioabsorbable stentsRon Waksman, Rajbabu Pakala
Current Pharmaceutical Design|January 7, 2011
Polymers for drug eluting stentsTed Parker, Vipul Davé, Robert Falotico
Current Pharmaceutical Design|September 8, 2010
3-phenyl-1H-indole-5-sulfonamides: structure-based drug design of a promising class of carbonic anhydrase inhibitorsOzlen Güzel, Alessio Innocenti, Daniela Vullo, et al.
Current Pharmaceutical Design|September 8, 2010
Brucella carbonic anhydrases: new targets for designing anti-infective agentsJean-Yves Winum, Stephan Köhler, Claudiu T Supuran
Current Pharmaceutical Design|December 17, 2010
Insulin, thrombine, ERK1/2 kinase and vascular smooth muscle cells proliferationEsma R Isenović, Sanja Soskić, Andreja Trpković, et al.
Current Pharmaceutical Design|December 28, 2010
3D modelling of three pro-inflammatory molecules in selected fish speciesSusan Costantini, Angelo M Facchiano, Elisa Randelli, et al.
Current Pharmaceutical Design|December 28, 2010
Inflammatory response in molluscs: cross-taxa and evolutionary considerationsE Ottaviani, A Franchini, D Malagoli
Pageof 1,064

Showing results (11-20 of 10,640) with videos related to

Sort By:
Pageof 1,064
Current Pharmaceutical Design|January 21, 2011
P-selectin antagonism in inflammatory diseaseKevin J Woollard, Jaye Chin-Dusting
Current Pharmaceutical Design|January 21, 2011
Cytoprotection by natural and synthetic polyphenols in the heart: novel mechanisms and perspectivesFan Jiang, Catherine W T Chang, Gregory J Dusting
Current Pharmaceutical Design|January 7, 2011
Pathobiology of stent thrombosis after drug-eluting stent implantationMarc Vorpahl, Saami K Yazdani, Masataka Nakano, et al.
Current Pharmaceutical Design|January 7, 2011
Biodegradable and bioabsorbable stentsRon Waksman, Rajbabu Pakala
Current Pharmaceutical Design|January 7, 2011
Polymers for drug eluting stentsTed Parker, Vipul Davé, Robert Falotico
Current Pharmaceutical Design|September 8, 2010
3-phenyl-1H-indole-5-sulfonamides: structure-based drug design of a promising class of carbonic anhydrase inhibitorsOzlen Güzel, Alessio Innocenti, Daniela Vullo, et al.
Current Pharmaceutical Design|September 8, 2010
Brucella carbonic anhydrases: new targets for designing anti-infective agentsJean-Yves Winum, Stephan Köhler, Claudiu T Supuran
Current Pharmaceutical Design|December 17, 2010
Insulin, thrombine, ERK1/2 kinase and vascular smooth muscle cells proliferationEsma R Isenović, Sanja Soskić, Andreja Trpković, et al.
Current Pharmaceutical Design|December 28, 2010
3D modelling of three pro-inflammatory molecules in selected fish speciesSusan Costantini, Angelo M Facchiano, Elisa Randelli, et al.
Current Pharmaceutical Design|December 28, 2010
Inflammatory response in molluscs: cross-taxa and evolutionary considerationsE Ottaviani, A Franchini, D Malagoli
Pageof 1,064